Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 74,983 | 31,875 | -34,004 | -18,412 | -18,073 |
| Depreciation Amortization | 92 | 299 | 38 | 46 | 43 |
| Income taxes - deferred | -32,971 | N/A | N/A | N/A | N/A |
| Accounts receivable | 4,549 | -10,537 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 138 | 1,780 | 392 | 1,012 | -861 |
| Other Working Capital | -4,112 | -1,096 | 4,267 | 2,029 | -884 |
| Other Operating Activity | 2,355 | 12,291 | 3,159 | 1,582 | 1,811 |
| Operating Cash Flow | $45,034 | $34,612 | $-26,148 | $-13,743 | $-17,964 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -10,000 | -34,725 | -36,791 | -4 | -69 |
| PPE Investments | -11 | -19 | -92 | N/A | -96 |
| Purchase Of Investment | 5,000 | 71,969 | 21,800 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | 0 | 3,717 |
| Investing Cash Flow | $-5,011 | $37,225 | $-15,083 | $-4 | $3,553 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 758 | 1,116 | 298 | 57,350 | 80 |
| Other Financing Activity | -56 | 0 | -5 | 0 | -11 |
| Financing Cash Flow | $702 | $1,116 | $293 | $57,350 | $69 |
| Beginning Cash Position | 89,512 | 16,559 | 57,497 | 13,893 | 28,235 |
| End Cash Position | 130,237 | 89,512 | 16,559 | 57,497 | 13,893 |
| Net Cash Flow | $40,725 | $72,953 | $-40,937 | $43,604 | $-14,342 |
| Free Cash Flow | |||||
| Operating Cash Flow | 45,034 | 34,612 | -26,148 | -13,743 | -17,964 |
| Capital Expenditure | -11 | -19 | -92 | N/A | -96 |
| Free Cash Flow | 45,023 | 34,593 | -26,240 | -13,743 | -18,060 |